Adrian Kilcoyne is Chief Medical Officer of HUMANIGEN, INC. Currently has a direct ownership of 12,000 shares of HGEN, which is worth approximately $0. The most recent transaction as insider was on Mar 09, 2022, when has been sold 5,000 shares (Common Stock) at a price of $2.78 per share, resulting in proceeds of $13,900. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12K
0% 3M change
0% 12M change
Total Value Held $0

Adrian Kilcoyne Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 09 2022
BUY
Open market or private purchase
$13,900 $2.78 p/Share
5,000 Added 29.41%
12,000 Common Stock
Mar 08 2022
BUY
Open market or private purchase
$17,710 $2.53 p/Share
7,000 Added 50.0%
7,000 Common Stock

Also insider at

CELU
Celularity Inc Healthcare
AK

Adrian Kilcoyne

Chief Medical Officer
Short Hills, NJ

Track Institutional and Insider Activities on HGEN

Follow HUMANIGEN, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HGEN shares.

Notify only if

Insider Trading

Get notified when an Humanigen, Inc insider buys or sells HGEN shares.

Notify only if

News

Receive news related to HUMANIGEN, INC

Track Activities on HGEN